Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort

by Dirk Grünhagen, Maureen J B Aarts, Ferry A L M Eskens, Kristien B M I Keymeulen, Lukas B Been, Alexander van Akkooi, Mathilde Jalving, Margot E T Tesselaar
Published 2020-07-01

ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study

by Marit A. C. Vermunt, Debbie G. J. Robbrecht, Lot A. Devriese, Julie M. Janssen, Bas Thijssen, Marianne Keessen, Maarten vanEijk, Rob Kessels, Ferry A. L. M. Eskens, Jos H. Beijnen, Niven Mehra, Andries M. Bergman
Published 2021-08-01

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634

by Florence Atrafi, Ruben A. G. van Eerden, Stijn L. W. Koolen, Peter de Bruijn, Cristianne J. F. Rijcken, Rob Hanssen, Ferry A. L. M. Eskens, Martijn P. Lolkema, Esther Oomen-de Hoop, Jeffrey Damman, Ron H. J. Mathijssen
Published 2021-07-01

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

by Job van Riet, Harmen J. G. van de Werken, Edwin Cuppen, Ferry A. L. M. Eskens, Margot Tesselaar, Linde M. van Veenendaal, Heinz-Josef Klümpen, Marcus W. Dercksen, Gerlof D. Valk, Martijn P. Lolkema, Stefan Sleijfer, Bianca Mostert
Published 2021-07-01

CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

by Hendrik-Tobias Arkenau, Marta Gil-Martin, Fiona Thistlethwaite, Karen A. Autio, Patrick A. Ott, Johanna Bendell, Patricia LoRusso, Valentina Boni, Alexander Spira, Javier Garcia-Corbacho, Mark Stroh, Elisabeth G.E. De Vries, Ferry A.L.M. Eskens, Nataliya Uboha, Manreet Randhawa, Greg Durm, Alison L. Hannah
Published 2021-07-01

Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)

by Mustafa Suker, Joost J. Nuyttens, Ferry A.L.M. Eskens, Brigitte C.M. Haberkorn, Peter-Paul L.O. Coene, Erwin van der Harst, Bert A. Bonsing, Alexander L. Vahrmeijer, J.Sven D. Mieog, Rutger Jan Swijnenburg, Daphne Roos, B.Groot. Koerkamp, Casper H.J. van Eijck
Published 2019-12-01

Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study

by Rogier Baak, François E. J. A. Willemssen, Yvette van Norden, Ferry A. L. M. Eskens, Maaike T. W. Milder, Ben J. M. Heijmen, Bas Groot Koerkamp, Dave Sprengers, Lydi M. J. W. van Driel, Heinz-Josef Klümpen, Wilhelm den Toom, Merel S. Koedijk, Jan N. M. IJzermans, Alejandra Méndez Romero
Published 2021-08-01

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma

by Krijn K. Dijkstra, Krijn K. Dijkstra, José G. van den Berg, Fleur Weeber, Fleur Weeber, Joris van de Haar, Joris van de Haar, Arno Velds, Sovann Kaing, Sovann Kaing, Dennis D. G. C. Peters, Ferry A. L. M. Eskens, Derk-Jan A. de Groot, Margot E. T. Tesselaar, Emile E. Voest, Emile E. Voest
Published 2021-03-01